Compartir
Título
Resumen de tesis. Preclinical evaluation of BH3-mimetics targeting MCL-1 (S63845) and BCL-2 (venetoclax) in multiple myeloma
Otros títulos
Preclinical evaluation of BH3-mimetics targeting MCL-1 (S63845) and BCL-2 (venetoclax) in multiple myeloma
Autor(es)
Director(es)
Palabras clave
Tesis y disertaciones académicas
Universidad de Salamanca (España)
Tesis Doctoral
Academic dissertations
Hematología
Mieloma múltiple
Clasificación UNESCO
3207.08 Hematología
Fecha de publicación
2020-06
Abstract
[EN] Multiple myeloma (MM) is a hematologic neoplasm characterized by the proliferation of
clonal plasma cells (PCs) in the bone marrow (BM). The substitution of normal BM cells
by MM cells results in cytopenias responsible, among other factors, for the
immunodeficiency observed in these patients, and also in the production of monoclonal
immunoglobulins (Igs) that can lead to renal failure. Other symptoms as hypercalcemia
and osteolysis are direct consequences of the interaction of malignant PCs with the BM
microenvironment.
URI
Collections